EE200200088A - Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks - Google Patents

Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks

Info

Publication number
EE200200088A
EE200200088A EEP200200088A EEP200200088A EE200200088A EE 200200088 A EE200200088 A EE 200200088A EE P200200088 A EEP200200088 A EE P200200088A EE P200200088 A EEP200200088 A EE P200200088A EE 200200088 A EE200200088 A EE 200200088A
Authority
EE
Estonia
Prior art keywords
hyperlipidemia
treatment
sulfonamides
medicament
bis
Prior art date
Application number
EEP200200088A
Other languages
English (en)
Estonian (et)
Inventor
Kirsch Reinhard
Schaefer Hans-Ludwig
Falk Eugen
Krass Norbert
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200200088A publication Critical patent/EE200200088A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
EEP200200088A 1999-09-01 2000-08-17 Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks EE200200088A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19941559A DE19941559A1 (de) 1999-09-01 1999-09-01 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie
PCT/EP2000/008026 WO2001016096A2 (de) 1999-09-01 2000-08-17 Verwendung von bissulfonamiden zur herstellung von medikamenten zur prophylaxe oder behandlung von hyperlipidämie

Publications (1)

Publication Number Publication Date
EE200200088A true EE200200088A (et) 2003-04-15

Family

ID=7920369

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200088A EE200200088A (et) 1999-09-01 2000-08-17 Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks

Country Status (23)

Country Link
US (1) US6632838B1 (pl)
EP (1) EP1237859B1 (pl)
JP (1) JP4982021B2 (pl)
KR (1) KR20020023429A (pl)
CN (1) CN1384742A (pl)
AT (1) ATE380789T1 (pl)
AU (1) AU775336B2 (pl)
BR (1) BR0013723A (pl)
CA (1) CA2383783A1 (pl)
CZ (1) CZ2002708A3 (pl)
DE (2) DE19941559A1 (pl)
EE (1) EE200200088A (pl)
HR (1) HRP20020178A2 (pl)
HU (1) HUP0204282A2 (pl)
IL (1) IL148147A0 (pl)
MX (1) MXPA02001740A (pl)
NO (1) NO20020812L (pl)
NZ (1) NZ517485A (pl)
PL (1) PL353205A1 (pl)
RU (1) RU2002107996A (pl)
SK (1) SK2722002A3 (pl)
WO (1) WO2001016096A2 (pl)
ZA (1) ZA200201592B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010232A (es) * 2001-05-11 2004-03-16 Biovitrum Ab Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
US7718650B2 (en) * 2001-05-11 2010-05-18 Biovitrum Ab Aryl sulfonamide compounds for treating obesity
RS88803A (sr) * 2001-05-11 2007-02-05 Biovitrum Ab., Nova jedinjenja arilsulfonamida za lečenje gojaznosti, dijabetesa tipa ii i poremećaja cns
WO2006012025A1 (en) * 2004-06-25 2006-02-02 Polyone Corporation Intumescent polyolefin nanocomposites and their use
JP4925629B2 (ja) * 2005-09-02 2012-05-09 住友化学株式会社 スルホンアミド化合物
WO2008129288A2 (en) * 2007-04-19 2008-10-30 Boehringer Ingelheim International Gmbh Disulfonamides useful in the treatment of inflammation
TW200930369A (en) * 2007-11-15 2009-07-16 Astrazeneca Ab Bis-(sulfonylamino) derivatives in therapy
UY31468A1 (es) * 2007-11-15 2009-07-17 Derivados bis-(sulfonilamino) en terapia 065
US20090163586A1 (en) * 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
WO2010132016A1 (en) * 2009-05-14 2010-11-18 Astrazeneca Ab Bis-(sulfonylamino) derivatives for treatment of pain and inflammation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353357A (en) * 1970-09-14 1974-05-15 Pfizer Substituted 5-sulphamylbenzoic acids
NL7310889A (pl) * 1972-08-12 1974-02-14
DE2459394A1 (de) * 1974-12-16 1976-06-24 Hoechst Ag Basisch substituierte benzol-1,3- disulfonamide und verfahren zu ihrer herstellung
FR2517202B1 (fr) * 1981-12-02 1986-07-04 Choay Sa Compositions pharmaceutiques presentant des proprietes normolipemiantes et contenant des composes ayant une structure du type benzenesulfonamides n-substitues
DE3713757A1 (de) * 1987-04-24 1988-11-10 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
DE3905075A1 (de) * 1989-02-18 1990-08-30 Hoechst Ag Benzolsulfonamide und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
MXPA02001740A (es) 2002-08-06
HUP0204282A2 (hu) 2003-06-28
NO20020812L (no) 2002-04-30
JP2003508381A (ja) 2003-03-04
RU2002107996A (ru) 2003-11-20
CZ2002708A3 (cs) 2002-05-15
CN1384742A (zh) 2002-12-11
ZA200201592B (en) 2003-01-29
WO2001016096A2 (de) 2001-03-08
JP4982021B2 (ja) 2012-07-25
AU775336B2 (en) 2004-07-29
EP1237859B1 (de) 2007-12-12
WO2001016096A3 (de) 2002-07-04
CA2383783A1 (en) 2001-03-08
NZ517485A (en) 2004-01-30
BR0013723A (pt) 2002-05-07
HRP20020178A2 (en) 2004-02-29
DE19941559A1 (de) 2001-03-15
SK2722002A3 (en) 2002-07-02
PL353205A1 (pl) 2003-11-03
DE50014850D1 (de) 2008-01-24
NO20020812D0 (no) 2002-02-19
US6632838B1 (en) 2003-10-14
EP1237859A2 (de) 2002-09-11
AU7409900A (en) 2001-03-26
IL148147A0 (en) 2002-09-12
ATE380789T1 (de) 2007-12-15
KR20020023429A (ko) 2002-03-28

Similar Documents

Publication Publication Date Title
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
BR0112589A (pt) Derivados de heteroarila e sua aplicação como medicamento
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
DE50310516D1 (de) Fredericamycin-derivate
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
IL171977A (en) Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
DE60034240D1 (de) Drogen zur behandlung maligner tumoren
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
NO20050073L (no) Ringsubstituerte difenylazetidinoner, deres fremstilling, deres anvendelse samt legemidler inneholdende forbindelsene
SE0202429D0 (sv) Novel Compounds
NO20023486L (no) Forbindelser av pyrroltypen, perapater inneholdende forbindelser samt deres anvendelse for behandling av cancer- ogvirale sykdommer
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
NO20020812D0 (no) Anvendelse av bissulfonamider for fremstilling av legemidler for profylakse eller behandling av hyperlipidemi
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
PT1156805E (pt) Utilizacao de sistenas piliciclicos de tiazole para a fabricacao de medicamentospara a profilaxia ou o tratamento de obesidade
TR200102306T2 (tr) Faktör Xa önleyici olarak heterosiklik türevler.
BR0116263A (pt) Derivados de diidroindol e tetraidroquinolina
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
SE0004827D0 (sv) Therapeutic compounds
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων